Figure 2 Figure 3 5 Effects of GLP-1 receptor agonists on biomarkers of inflammation In a systematic review and meta-analysis conducted by Bray et al., data from 40 randomized controlled trials were analyzed to examine the effects of GLP-1RAs on biomarkers of inflammation and oxidative stress in patients with type 2 diabetes
But thats what glucagon-like peptide-1 (GLP-1) receptor agonist medications, like Wegovy and Ozempic can help you do
Use only under the supervision of a qualified healthcare professional
Not enrolled or qualified for any federal, state, or government program like Medicaid, Low Income Subsidy, or Veterans Affairs (VA) Benefits
No administration The materials are not represented or supplied for human or animal administration, consumption, treatment, diagnosis, or personal experimentation